Co-administration of lipopolysaccharide and d-galactosamine induces genotoxicity in mouse liver
Abstract The acute liver injury (ALI) and hepatic fibrosis caused by the co-treatment of lipopolysaccharide (LPS)/d-galactosamine (D-GalN) have been extensively studied. However, whether LPS/D-GalN are genotoxic has been left unknown. In this study, male mice were divided into eight groups with eigh...
Guardado en:
Autores principales: | Wenjing Dong, Erqun Song, Yang Song |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c9a5744ca4794edb9ad95e26955b2b1e |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Saccharomyces boulardii Administration Changes Gut Microbiota and Attenuates D-Galactosamine-Induced Liver Injury
por: Lei Yu, et al.
Publicado: (2017) -
Oyster-Derived Tyr-Ala (YA) Peptide Prevents Lipopolysaccharide/D-Galactosamine-Induced Acute Liver Failure by Suppressing Inflammatory, Apoptotic, Ferroptotic, and Pyroptotic Signals
por: Adrian S. Siregar, et al.
Publicado: (2021) -
Bifidobacterium pseudocatenulatum LI09 and Bifidobacterium catenulatum LI10 attenuate D-galactosamine-induced liver injury by modifying the gut microbiota
por: Daiqiong Fang, et al.
Publicado: (2017) -
Genotoxic and oxidative effect of duloxetine on mouse brain and liver tissues
por: Isela Álvarez-González, et al.
Publicado: (2021) -
<named-content content-type="genus-species">Bifidobacterium longum</named-content> R0175 Protects Rats against <sc>d</sc>-Galactosamine-Induced Acute Liver Failure
por: Kaicen Wang, et al.
Publicado: (2020)